about
Immune biomarker panel monitoring utilizing IDO enzyme activity and CD4 ATP levels: prediction of acute rejection vs. viral replication eventsHigh activity of indoleamine 2,3-dioxygenase is associated with renal insufficiency in Puumala hantavirus induced nephropathia epidemica.Verification of association of elevated serum IDO enzyme activity with acute rejection and low CD4-ATP levels with infection.Stable pediatric kidney transplant recipients run higher urine indoleamine 2, 3 dioxygenase (IDO) levels than healthy children.Knockdown of toll-like receptor 4 signaling pathways ameliorate bone graft rejection in a mouse model of allograft transplantationMolecular signatures of T-cell inhibition in HIV-1 infection.The tryptophan/kynurenine pathway, systemic inflammation, and long-term outcome after kidney transplantation.Serum indoleamine 2,3 dioxygenase and tryptophan and kynurenine ratio using the UPLC-MS/MS method, in patients undergoing peritoneal dialysis, hemodialysis, and kidney transplantation.Function of the tryptophan metabolite, L-kynurenine, in human corneal endothelial cells.Expression analysis of Foxp3 in T cells from bovine leukemia virus infected cattle.Immunomodulation by IFN-γ in patients with resistant infections and accompanying bronchiolitis obliterans following allo-SCT.Infiltrating cellular pattern in kidney graft biopsies translates into forkhead box protein 3 up-regulation and p16INK4α senescence protein down-regulation in patients treated with belatacept compared to cyclosporin A.Indoleamine 2,3 dioxygenase contributes to transferable tolerance in rat red blood cell inducible model of experimental autoimmune haemolytic anaemia.Modulation of antigen presenting cell functions during chronic HPV infection.Indoleamine 2,3-dioxygenase-expressing peripheral cells in rheumatoid arthritis and systemic lupus erythematosus: a cross-sectional study.
P2860
Q34805304-7B5F95EB-8BB7-4B8A-AECB-D74A875F81D6Q37416875-32A6447F-4088-4767-B2DD-ECCA36B24711Q37419213-C8768AB1-5992-49E9-AD98-D938AD96FD19Q37695092-0865D94B-D7A8-432F-86EE-54260E2636EDQ37743250-EEFEBE58-5F82-49BD-857D-3EBE0819E810Q38091548-4E3BF785-0321-4018-B389-7A07970356E0Q38793765-A634C579-F322-4FA5-BF74-5F7FA1F32A45Q39552187-FEA39ABC-C660-4875-B3C8-0E436BA73D14Q39825658-B35C86AF-8987-4559-BA47-64515CBCBF91Q42276749-23DCD20A-827C-417A-BDDC-1D0FF8209A92Q43592901-8C26381A-203B-4542-9174-5BCA254E2BB1Q45910333-C91212D8-69AC-4695-954D-5292BAEE3C8AQ45945999-7B88EC3C-8944-49C4-B9A3-F38292A15A6CQ49591682-C039AFE4-9D74-4EDA-B668-4716A8BB9F04Q51597260-39E9F943-06AC-4C51-91F3-8F536888D7A1
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Indoleamine 2,3-dioxygenase in transplantation.
@en
Indoleamine 2,3-dioxygenase in transplantation.
@nl
type
label
Indoleamine 2,3-dioxygenase in transplantation.
@en
Indoleamine 2,3-dioxygenase in transplantation.
@nl
prefLabel
Indoleamine 2,3-dioxygenase in transplantation.
@en
Indoleamine 2,3-dioxygenase in transplantation.
@nl
P2860
P1433
P1476
Indoleamine 2,3-dioxygenase in transplantation.
@en
P2093
David J Nikolic-Paterson
William R Mulley
P2860
P304
P356
10.1111/J.1440-1797.2007.00921.X
P577
2008-01-23T00:00:00Z